# 64 Cu-DOTA-alendronate PET Imaging in Localizing and Characterizing Breast Calcifications in Participants Before Undergoing Mastectomy

> **NCT03542695** · EARLY_PHASE1 · COMPLETED · sponsor: **City of Hope Medical Center** · enrollment: 1 (actual)

## Conditions studied

- Breast Carcinoma
- Calcification

## Interventions

- **PROCEDURE:** Computed Tomography
- **DRUG:** Copper Cu-64-DOTA-alendronate
- **OTHER:** Pharmacokinetic Study
- **PROCEDURE:** Positron Emission Tomography

## Key facts

- **NCT ID:** NCT03542695
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-03
- **Primary completion:** 2024-05-31
- **Final completion:** 2024-05-31
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2024-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03542695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03542695, "64 Cu-DOTA-alendronate PET Imaging in Localizing and Characterizing Breast Calcifications in Participants Before Undergoing Mastectomy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03542695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*